Black Rock Inc. Ocular Therapeutix, Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Black Rock Inc. holds 11,520,326 shares of OCUL stock, worth $135 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,520,326
              Previous 8,063,703
              
        
           42.87%
        
      
          
        Holding current value
$135 Million
            Previous $73.4 Million
            
        
           7.39%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  13 transactions
	
  Others Institutions Holding OCUL
# of Institutions
206Shares Held
137MCall Options Held
743KPut Options Held
321K- 
    
      Deep Track Capital, LP Greenwich, CT14.3MShares$167 Million4.71% of portfolio
- 
    
      Summer Road LLC West Palm Beach, FL13.9MShares$162 Million98.75% of portfolio
- 
    
      Vr Adviser, LLC New York, NY12.8MShares$149 Million23.46% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA8.39MShares$98.2 Million0.0% of portfolio
- 
    
      Avoro Capital Advisors LLC New York, NY7.4MShares$86.6 Million1.25% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $901M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...